Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

The RSC Nucleic Acids Group invites you to their Forum meeting, which will take place in-person at the RSC's iconic Burlington House in London. This is the NAG’s annual meeting, bringing together the ...

The variety of potentially useful dyes or haptenes available for fluorescent nucleic acid hybridization assays is far greater than what can be obtained from commercial sources 1,2. Since this ...

More than a year ago, computational scientists at the Department of Energy's Oak Ridge National Laboratory published a study ...

The team discovered that IPMK binds directly to SRF, altering the three-dimensional structure of the SRF protein ... More information: Hyoungjoon Ahn et al, Single-molecule analysis reveals that IPMK ...

In a joint initiative between the Universities of Geneva, Lausanne and Bern, and the EPFL the Dubochet Center for Imaging ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

The way in which the chain of amino acid units in a protein molecule is coiled and folded in space has been worked out for the first time. The protein is myoglobin, the molecule of which contains ...

Water is the most prevalent component of biomolecular simulations - from protein ensembles to nucleic acids - and ...

Linked to neurological disorders, repeat RNAs aggregate inside droplets but can be disassembled with an engineered piece of ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Insects possess a remarkable ability to develop innate immune memory, and the mechanisms underlying this process are becoming a central topic in innate immunity research.